• Our Services

    We offer best-in-class research and consulting services pertaining to the markets of all geographies. Our experienced team of business analysts and consultants has mastered fundamental and advanced market research in diverse industries.

  • Syndicated Research

    Syndicated research is the most cost-effective market research approach, which gives an analytical outlook of the competitive positioning, product positioning, and size estimation of the market at the micro level. Our off-the-shelf reports offer key market insights that industry stakeholders require to base their business strategy on. Our syndicated research services empower our clients to meet diverse market objectives.

  • Customized Research

    we also deliver customized research services to address specific needs of our clients. With a vast pool of adroit analysts who are proficient in market research, we take pride in tailoring our research services to meet our clients’ definite requirements and aid their business growth.

  • Consulting Services

    Businesses, today, need to adapt themselves to the changes that transpire in the market. Staying abreast of the market trends, therefore, becomes imperative for accomplishing business objectives.

  • Our Vision

    To be the most trusted partner in our clients' success endeavors

Showing posts with label Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics - Pipeline Analysis. Show all posts
Showing posts with label Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics - Pipeline Analysis. Show all posts

Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics - Pipeline Analysis , Clinical Trials & Results


Fibrodysplasia ossificans progressiva (FOP), also known as myositis ossificans progressive, is a rare inherited connective tissue disorder characterized by abnormal bone development in ligaments, tendons, and skeletal muscles.
Precisely, FOP causes the body's skeletal muscles and soft connective tissues to undergo a metamorphosis, transforming into bone, gradually locking joints and making movement difficult. FOP is inherited as an autosomal dominant trait with complete penetrance. Standard therapies available for FOP are; corticosteroids and non-steroidal anti-inflammatory medication for pain and swelling associated with FOP; occupational therapy; and genetic counselling.

Request to Get Free Sample Pages at:
                                                    https://www.pharmaproff.com/request-sample/1084

Regeneron Pharmaceuticals Inc. is in the process of developing REGN2477 as an activin A antibody which act as an activin modulator for the treatment of FOP. Some of the companies in FOP pipeline are Clementia Pharmaceuticals Inc. and Regeneron Pharmaceuticals Inc. among others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Share:

Profile

Popular Posts

APSense

Labels

Linkedin Profile

APSense

Business Network

Recent Posts

Research Pages